XELLERA Trademark

Trademark Overview


On Monday, May 27, 2019, a trademark application was filed for XELLERA with the United States Patent and Trademark Office. The USPTO has given the XELLERA trademark a serial number of 88447138. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Thursday, November 5, 2020. This trademark is owned by XELLERA THERAPEUTICS LIMITED. The XELLERA trademark is filed in the Chemical Products and Pharmaceutical Products categories with the following description:

Biological preparation for use in cell cultures other than for medical or veterinary use; Biological preparations for use in industry and science; Biological tissue cultures, other than for medical or veterinary purposes; Chemical additives for use in the manufacture of pharmaceuticals; Chemical preparations for scientific purposes, other than for medical or veterinary use; Chemical reagents, other than for medical or veterinary purpose; Chemical substances for analyses in laboratories, other than for medical or veterinary purposes; Chemicals for use in biotechnological manufacturing processes; Diagnostic preparations other than for medical or veterinary purposes; Nucleic acid for laboratory use; Stem cells, other than for medical or veterinary purposes

Biological tissue cultures for medical purposes; Biological tissue cultures for veterinary purposes; Cardiovascular agents for medical purposes; Cardiovascular pharmaceuticals; Cells for medical or clinical use; Chemical reagents for medical or veterinary purposes; Diagnostic preparations for medical purposes; Gene therapy products, namely, genetically engineered tissues for transplant purposes; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Medicinal preparations for regenerative and reparative therapies; Nucleic acid sequences and chemical reagents for medical and veterinary purposes; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical products for treating respiratory diseases; Stem cells for medical purposes; Stem cells for veterinary purposes; Surgical implants comprising living tissue; Synthetic peptides for the treatment of respiratory conditions; Veterinary preparations for regenerative and repara...
xellera

General Information


Serial Number88447138
Word MarkXELLERA
Filing DateMonday, May 27, 2019
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateThursday, November 5, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Indication of Colors claimedColor is not claimed as a feature of the mark.
Description of MarkThe mark consists of the stylized design of the letter "X" and the stylized wording "ellera".
Goods and ServicesBiological preparation for use in cell cultures other than for medical or veterinary use; Biological preparations for use in industry and science; Biological tissue cultures, other than for medical or veterinary purposes; Chemical additives for use in the manufacture of pharmaceuticals; Chemical preparations for scientific purposes, other than for medical or veterinary use; Chemical reagents, other than for medical or veterinary purpose; Chemical substances for analyses in laboratories, other than for medical or veterinary purposes; Chemicals for use in biotechnological manufacturing processes; Diagnostic preparations other than for medical or veterinary purposes; Nucleic acid for laboratory use; Stem cells, other than for medical or veterinary purposes
Goods and ServicesBiological tissue cultures for medical purposes; Biological tissue cultures for veterinary purposes; Cardiovascular agents for medical purposes; Cardiovascular pharmaceuticals; Cells for medical or clinical use; Chemical reagents for medical or veterinary purposes; Diagnostic preparations for medical purposes; Gene therapy products, namely, genetically engineered tissues for transplant purposes; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Medicinal preparations for regenerative and reparative therapies; Nucleic acid sequences and chemical reagents for medical and veterinary purposes; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical products for treating respiratory diseases; Stem cells for medical purposes; Stem cells for veterinary purposes; Surgical implants comprising living tissue; Synthetic peptides for the treatment of respiratory conditions; Veterinary preparations for regenerative and reparative therapies
Translation of Words in MarkThe wording "XELLERA" has no meaning in a foreign language.

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateTuesday, June 11, 2019
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, June 11, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameXELLERA THERAPEUTICS LIMITED
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressHUNG HOM, KLN
HK

Trademark Events


Event DateEvent Description
Thursday, November 5, 2020ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Thursday, November 5, 2020ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Friday, April 24, 2020NOTIFICATION OF FINAL REFUSAL EMAILED
Friday, April 24, 2020FINAL REFUSAL E-MAILED
Friday, April 24, 2020FINAL REFUSAL WRITTEN
Thursday, March 26, 2020DIVISIONAL PROCESSING COMPLETE
Friday, February 21, 2020DIVISIONAL REQUEST RECEIVED
Tuesday, March 24, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, February 27, 2020ASSIGNED TO LIE
Friday, February 21, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, February 21, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, February 21, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, February 21, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, February 21, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, February 21, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, February 21, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, February 21, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, February 21, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, February 21, 2020TEAS REQUEST TO DIVIDE RECEIVED
Tuesday, December 31, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, December 31, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, August 21, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, August 21, 2019NON-FINAL ACTION E-MAILED
Wednesday, August 21, 2019NON-FINAL ACTION WRITTEN
Thursday, August 15, 2019ASSIGNED TO EXAMINER
Tuesday, June 11, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, May 30, 2019NEW APPLICATION ENTERED IN TRAM